Log in
Enquire now
Neurophth Therapeutics

Neurophth Therapeutics

Neurophth Therapeutics is an ophthalmology Gene Therapy.

OverviewStructured DataIssuesContributors

Contents

neurophth.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Induced pluripotent stem cell
Induced pluripotent stem cell
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Location
China
China
Wuhan
Wuhan
Pitchbook URL
pitchbook.com/profiles...433947-97
Email Address
info@neurophth.com
Investors
‌
CMG-SDIC Capital Management
0
‌
Qiji Zhiguang Fund
‌
Guofang Capital
Fosun International
Fosun International
Total Funding Amount (USD)
122,000,000
Latest Funding Round Date
November 23, 2021
Latest Funding Type
Series C
Series C
Country
China
China
Headquarters
Wuhan
Wuhan

Other attributes

Company Operating Status
Active
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Neurophth Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.